MEDIUM confidence: 100% data completeness, but the composite (60) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-10-18.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
No recent open-market insider transactions.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 10.0%/yr (revenue basis).
Base free cash flow $250M (avg FY2023–FY2025; latest year $232M) · equity value $9.1B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $939M— | $1.8B+92.3% | $2.2B+19.5% | $2.3B+8.4% | $2.6B+10.2% |
| EPS (dil.) | $-3.21— | $2.33n/m | $5.36+130.0% | $4.38-18.3% | $3.77-13.9% |
| Free Cash Flow | $89M— | $330M+270.2% | $350M+6.0% | $169M-51.9% | $232M+37.8% |
| Gross Margin | 21.4% | 32.1%+10.7pp | 32.9%+0.8pp | 36.1%+3.2pp | 9.9%-26.2pp |
| Operating Margin | -6.2% | 18.1%+24.4pp | 21.0%+2.9pp | 21.0%-0.0pp | 18.9%-2.0pp |
| Net Margin | -18.8% | 7.1%+26.0pp | 14.4%+7.3pp | 11.6%-2.8pp | 9.4%-2.2pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $140 avg across 7 analysts.
Buy-rated share 100% → 93% over ~3 months (-7pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $1.31 | $1.42 | +8.4% |
| Apr 2026 | $2.03 | $2.32 | +14.3% |
| Feb 2026 | $2.22 | $2.38 | +7.2% |
| Nov 2025 | $1.59 | $0.55 | -65.4% |
| Aug 2025 | $2.31 | $1.17 | -49.4% |
| May 2025 | $1.79 | $2.08 | +16.2% |
| Feb 2025 | $1.21 | $1.15 | -5.0% |
| Nov 2024 | $1.21 | $0.94 | -22.3% |
The QScore of 60 for RHP indicates a moderately attractive stock, with the short-term score of 65 diverging from the long-term score of 54 by 11 points. RHP scores high on momentum, driven by its 53.8% return over the past year, and exhibits a relatively low risk profile with a beta of 1.2. However, the stock trades at a premium, with a P/E of 30.8 and P/B of 11.2, which weighs on its value score, while its profitability score is also subdued due to a moderate ROE of 36.4%.